首页> 外国专利> VITREOUS FORM OF 8-3-N-E-3-(6-ACETAMIDOPYRIDIN-3-YL)ACRYLOYLGLYCYL-N- METHYLAMINO-2,6-DICHLORO-BENZYLOXY-2-METHYLQUINOLINE, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION

VITREOUS FORM OF 8-3-N-E-3-(6-ACETAMIDOPYRIDIN-3-YL)ACRYLOYLGLYCYL-N- METHYLAMINO-2,6-DICHLORO-BENZYLOXY-2-METHYLQUINOLINE, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION

机译:8- [3- [N- [E] -3-(6-乙酰胺基-3-基)丙烯酰基乙二醇] -N-甲基氨基] -2,6-二氯-苄基] -2-甲基喹啉的玻璃体形式,其制备方法制备和药物成分

摘要

FIELD: or- ganic chemistry, pharmacy. SUBSTANCE: invention relates to vitreous form of 8-[3-[N-(E)-3-(6-acetamidopyridin-3-yl)acryloyl-glycyl]-N-methylamino] -2,6-dichlorobenzyloxy] -2-methylquinoline. Invention relates also to method of its preparing by heating crystalline modification A or mixture of crystalline modification A and crystalline modification C of 8-[3-[N-(E)-3-(6-acetamidopyridin-3-yl)acryloyl-glycyl]-N-methylamino]-2,6-dichlorobenzyloxy] -2-methylquinoline hydrate at temperature below its melting point and the following cooling. Invention describes also pharmaceutical composition. This vitreous form shows good solubility and therefore it is useful for preparing medicinal agents used in treatment of bradykinin-mediated diseases. EFFECT: improved method of preparing, valuable medicinal properties. 8 cl, 6 dwg, 1 tbl
机译:领域:有机化学,药学。物质:本发明涉及8- [3- [N-(E)-3-(6-乙酰酰胺基吡啶-3-基)丙烯酰基-甘氨酰] -N-甲基氨基] -2,6-二氯苄氧基] -2-的玻璃体形式甲基喹啉。本发明还涉及通过加热8- [3- [N-(E)-3-(6-乙酰氨基吡啶-3-基)丙烯酰基-甘氨酰]的结晶变体A或结晶变体A和结晶变体C的混合物来制备其方法。 [-N-甲基氨基] -2,6-二氯苄氧基] -2-甲基喹啉水合物在低于其熔点的温度下冷却。本发明还描述了药物组合物。该玻璃状形式显示出良好的溶解性,因此可用于制备用于治疗缓激肽介导的疾病的药物。功效:改进的制备方法,有价值的药物特性。 8厘升,6载重吨,1桶

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号